ProShares - UltraShort Health Care (RXD) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören ProShares - UltraShort Health Care (RXD), 0 değerindeki bir Financial Services şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 18 Mar 2026ProShares - UltraShort Health Care (RXD) Finansal Hizmetler Profili
ProShares UltraShort Health Care (RXD) is a geared ETF providing -2x daily exposure to the S&P Health Care Select Sector Index, appealing to sophisticated investors seeking short-term, inverse exposure to the health care sector. It offers a tactical tool for hedging or potentially profiting from anticipated downturns in the health care market.
Yatırım Tezi
ProShares UltraShort Health Care (RXD) presents a tactical opportunity for investors with a bearish outlook on the health care sector. The fund's -2x leverage offers the potential for amplified gains when the S&P Health Care Select Sector Index declines. However, this leverage also magnifies losses if the index rises. Key considerations include the fund's daily reset feature, which can lead to performance erosion over longer holding periods, particularly in volatile markets. Investors should closely monitor health care sector trends, regulatory changes, and economic factors that could impact the index. RXD is best suited for short-term trading strategies and hedging purposes, rather than long-term investment.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- RXD seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the S&P Health Care Select SectorSM Index.
- The fund is designed for sophisticated investors with a high-risk tolerance and a short-term trading horizon.
- RXD offers intraday liquidity, allowing investors to buy and sell shares throughout the trading day.
- Due to the leveraged nature of the fund, its performance can deviate significantly from the underlying index over longer periods, especially in volatile markets.
- The fund's beta is -1.09, indicating an inverse correlation with the market.
Rakipler & Benzerleri
Güçlü Yönler
- Leveraged inverse exposure provides the potential for high returns in a declining health care market.
- Intraday liquidity allows for flexible trading strategies.
- Established brand recognition in the ETF market.
Zayıflıklar
- Leverage magnifies losses if the health care sector rises.
- Daily reset can lead to performance erosion over longer periods.
- High expense ratio compared to non-leveraged ETFs.
Katalizörler
- Upcoming: Potential for increased volatility in the health care sector due to upcoming regulatory changes.
- Ongoing: Continued economic uncertainty and geopolitical risks driving demand for inverse ETFs.
- Ongoing: Technological disruptions in the health care industry creating opportunities for short-term trading strategies.
Riskler
- Potential: Unexpected rallies in the health care sector leading to significant losses.
- Potential: Changes in regulations governing leveraged ETFs.
- Ongoing: High expense ratio compared to non-leveraged ETFs.
- Ongoing: Daily reset leading to performance erosion over longer periods.
Büyüme Fırsatları
- Increased Volatility in Healthcare Sector: Ongoing: The healthcare sector is subject to regulatory changes, drug pricing debates, and technological advancements, all of which can create volatility. RXD can capitalize on increased volatility as investors seek to hedge their portfolios or profit from short-term declines. The market size for inverse ETFs is directly correlated with market volatility, and the healthcare sector is expected to remain volatile due to political and economic factors.
- Rising Interest Rates: Ongoing: Rising interest rates can negatively impact growth stocks, including those in the healthcare sector. RXD can benefit from this trend as investors seek to hedge their exposure to healthcare companies that are sensitive to interest rate changes. The market for inverse ETFs that target interest rate-sensitive sectors is expected to grow as the Federal Reserve continues to tighten monetary policy.
- Geopolitical Risks: Ongoing: Geopolitical tensions and trade disputes can create uncertainty in global markets, leading to increased demand for safe-haven assets and inverse ETFs. RXD can benefit from this trend as investors seek to protect their portfolios from geopolitical risks. The market size for inverse ETFs that target specific sectors or countries is expected to grow as geopolitical risks remain elevated.
- Technological Disruption in Healthcare: Ongoing: Rapid technological advancements in healthcare, such as artificial intelligence and telemedicine, can disrupt traditional healthcare business models. RXD can capitalize on this disruption as investors seek to profit from the decline of companies that are slow to adapt to technological changes. The market for inverse ETFs that target disrupted industries is expected to grow as technology continues to transform the global economy.
- Increased Adoption of Short-Term Trading Strategies: Ongoing: The rise of online trading platforms and mobile apps has made it easier for investors to engage in short-term trading strategies. RXD is well-suited for short-term trading due to its leveraged inverse exposure. The market for leveraged and inverse ETFs is expected to grow as more investors adopt short-term trading strategies.
Fırsatlar
- Increased volatility in the health care sector due to regulatory changes and economic uncertainty.
- Growing demand for inverse ETFs as investors seek to hedge their portfolios.
- Expansion into new markets and product offerings.
Tehditler
- Changes in regulations governing leveraged ETFs.
- Increased competition from other ETF providers.
- Unexpected rallies in the health care sector.
Rekabet Avantajları
- First-mover advantage in offering leveraged inverse exposure to the S&P Health Care Select Sector Index.
- Established brand recognition in the ETF market.
- Proprietary trading strategies and risk management expertise.
RXD Hakkında
ProShares UltraShort Health Care (RXD) is designed for sophisticated investors seeking to achieve a multiple of the inverse of the daily performance of a specific index. Specifically, RXD aims to deliver two times the inverse (-2x) of the daily performance of the S&P Health Care Select Sector Index, before fees and expenses. This fund is not intended for long-term investment and is best suited for investors with a high-risk tolerance and a short-term trading horizon. The S&P Health Care Select Sector Index represents the health care sector of the S&P 500, including companies from industries such as pharmaceuticals, biotechnology, health care equipment, and health care services. RXD provides a way for investors to potentially profit from a decline in the value of these companies, using a leveraged inverse strategy. As an ETF, RXD offers intraday liquidity, allowing investors to buy and sell shares throughout the trading day. However, due to the leveraged nature of the fund, its performance can deviate significantly from the underlying index over longer periods, especially in volatile markets. Investors should carefully monitor their positions and understand the risks associated with leveraged and inverse ETFs.
Ne Yaparlar
- Provides leveraged inverse exposure to the S&P Health Care Select Sector Index.
- Offers a way to potentially profit from short-term declines in the health care sector.
- Designed for sophisticated investors with a high-risk tolerance.
- Trades like a stock on major exchanges.
- Offers intraday liquidity.
- Resets daily, which can lead to performance erosion over longer periods.
İş Modeli
- RXD generates revenue through management fees charged to investors.
- The fund's performance is directly linked to the performance of the S&P Health Care Select Sector Index.
- The fund uses a leveraged inverse strategy to amplify its returns.
Sektör Bağlamı
The asset management industry is characterized by intense competition, with firms vying for market share based on investment performance, fees, and product innovation. ETFs like RXD offer specialized exposure to specific sectors or investment strategies, catering to investors with diverse risk appetites and investment objectives. The health care sector, in particular, is subject to regulatory scrutiny and market volatility, creating opportunities for inverse ETFs like RXD to capitalize on short-term declines. The industry faces ongoing pressure to reduce fees and improve transparency, driving innovation in product design and distribution.
Kilit Müşteriler
- Sophisticated investors
- High-risk tolerance traders
- Investors seeking short-term exposure to the health care sector
- Investors hedging their portfolios against potential declines in health care stocks
Finansallar
Grafik & Bilgi
ProShares - UltraShort Health Care (RXD) hisse senedi fiyatı: Price data unavailable
Son Haberler
RXD için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
RXD için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
RXD için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, RXD'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
RXD Financial Services Hisse Senedi SSS
RXD için değerlendirilmesi gereken temel faktörler nelerdir?
ProShares - UltraShort Health Care (RXD) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Temel güçlü yan: Leveraged inverse exposure provides the potential for high returns in a declining health care market.. İzlenmesi gereken birincil risk: Potential: Unexpected rallies in the health care sector leading to significant losses.. Bu bir finansal tavsiye değildir.
RXD MoonshotScore'u nedir?
RXD şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
RXD verileri ne sıklıkla güncellenir?
RXD fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler RXD hakkında ne diyor?
RXD için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
RXD'a yatırım yapmanın riskleri nelerdir?
RXD için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Unexpected rallies in the health care sector leading to significant losses.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
RXD'ın P/E oranı nedir?
RXD için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için RXD'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
RXD aşırı değerli mi, yoksa düşük değerli mi?
ProShares - UltraShort Health Care (RXD)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
RXD'ın temettü verimi nedir?
ProShares - UltraShort Health Care (RXD) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- The AI analysis is pending and will provide further insights into the company's performance and outlook.
- Leveraged and inverse ETFs are complex financial instruments and are not suitable for all investors.